按人群和地点定制疫苗瓶规格的价值
本研究使用HERMES软件构建赞比亚常规疫苗供应链模拟模型,比较不同部位分配5剂和1剂麻疹-风疹(MR)疫苗瓶与基线10剂瓶的效果。结果显示,在所有地点替换为5剂MR瓶可最大程度减少开瓶浪费,但增加冷链利用并降低其他疫苗可得性;将5剂瓶定制到农村卫生机构或按平均接种场次规模分配,可减少冷链运输限制、提高总疫苗可得性并降低每剂接种总成本。
要点
- 所有地点使用5剂MR瓶可最大减少开瓶浪费,但增加冷链负担并降低其他疫苗可得性1%。
- 将5剂MR瓶定制到农村卫生机构或按平均场次规模分配,可提高总疫苗可得性1%并降低每剂成本0.01美元。
- 定制5剂MR瓶可减少开瓶浪费而不增加冷链利用,优于其他场景。
核心结论
- 在赞比亚,将5剂MR瓶定制到农村卫生机构或按平均接种场次规模分配,相比所有其他场景(无论开瓶阈值政策如何),通过减少开瓶浪费而不增加冷链利用,实现了最高的总疫苗可得性。
研究设计与样本
- 使用HERMES软件构建赞比亚常规疫苗供应链模拟模型。
- 基线为所有地点分配10剂MR瓶,并测试5剂和1剂MR瓶分配至以下场景:所有地点、农村地区、农村卫生机构、外展站点、平均MR场次规模<5和<10儿童的地点。
- 每个场景进行敏感性分析,MR开瓶阈值设为0%和50%。
主要发现
- 所有地点替换为5剂MR瓶导致MR开瓶浪费最大减少,节省573,892剂(50%开瓶阈值下节省103,161剂),MR可得性提高1%(9%)。
- 该场景增加冷链利用并导致其他疫苗可得性降低1%。
- 将5剂MR瓶定制到农村卫生机构或按平均场次规模分配,减少冷链运输限制,总疫苗可得性提高1%,每剂接种总成本降低0.01美元。
临床怎么用
- 在赞比亚,考虑将5剂MR瓶定制到农村卫生机构或按平均接种场次规模分配,以减少开瓶浪费并提高总疫苗可得性。
- 需权衡所有地点使用5剂瓶带来的冷链负担和其他疫苗可得性下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frequently, a country will procure a single vaccine vial size, but the question remains whether tailoring the use of different size vaccine vial presentations based on populations or location characteristics within a single country could provide additional benefits, such as reducing open vial wastage (OVW) or reducing missed vaccination opportunities. METHODS: Using the Highly Extensible Resource for Modeling Supply Chains (HERMES) software, we built a simulation model of the Zambia routine vaccine supply chain. At baseline, we distributed 10-dose Measles-Rubella (MR) vials to all locations, and then distributed 5-dose and 1-dose MR vials to (1) all locations, (2) rural districts, (3) rural health facilities, (4) outreach sites, and (5) locations with average MR session sizes <5 and <10 children. We ran sensitivity on each scenario using MR vial opening thresholds of 0% and 50%, i.e. a healthcare worker opens an MR vaccine for any number of children (0%) or if at least half will be used (50%). RESULTS: Replacing 10-dose MR with 5-dose MR vials everywhere led to the largest reduction in MR OVW, saving 573,892 doses (103,161 doses with the 50% vial opening threshold) and improving MR availability by 1% (9%). This scenario, however, increased cold chain utilization and led to a 1% decrease in availability of other vaccines. Tailoring 5-dose MR vials to rural health facilities or based on average session size reduced cold transport constraints, increased total vaccine availability (+1%) and reduced total cost per dose administered (-$0.01) compared to baseline. CONCLUSIONS: In Zambia, tailoring 5-dose MR vials to rural health facilities or by average session size results in the highest total vaccine availability compared to all other scenarios (regardless of OVT policy) by reducing open vial wastage without increasing cold chain utilization.
引用
- Wedlock PT, Mitgang EA, Haidari LA, et al. The value of tailoring vial sizes to populations and locations. Vaccine. 2018. PMID: 30578087. doi:10.1016/j.vaccine.2018.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。